Illumina Inc. (NASDAQ:ILMN), a leading provider of next-generation sequencing (NGS ... and marketing life science tools and integrated systems for genetic analysis. The company’s core business ...

Optimal therapeutic targeting of cancer involves clonal signals which are expressed within all cancer cellsGradalis applies a novel clinically ...

Setting the standard through dynamic genomic technology platform, improving patient outcomes AURORA, Colo., /PRNewswire/ -- ...

The leaders of Canada and Mexico have held talks with the Trump administration to stave off tariffs, but China has instead embarked on a tit-for-tat approach.

Beijing banned imports of Illumina’s gene-sequencing machines in response to U.S. tariffs.

The San Diego company also lowered its financial guidance for 2025 in response to China’s import restrictions.

Illumina on Monday lowered its annual forecast and said it plans to cut $100 million in spending after China announced a ban ...

Illumina (ILMN) responded to the March 4 notice from the China Ministry of Commerce that the company is not permitted to export sequencing ...

Amid increasing economic tensions with the United States, China recently announced that it would ban Illumina, a U.S.-based company and the ...

Illumina is reducing its forecast for this year’s financial performance and cutting $100 million in spending because China barred sales of the company’s gene-sequencing machines. San Diego ...

(RTTNews) - Illumina, Inc. (ILMN) responded on Monday to the notice from the China Ministry of Commerce stating that it is not permitted to export sequencing instruments into China. Illumina said ...